Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -264,457 | -193,569 | -143,948 | -180,360 | -117,194 |
| Depreciation Amortization | 8,534 | 5,140 | 8,233 | 11,234 | 7,788 |
| Accounts receivable | N/A | N/A | N/A | 6,000 | -6,000 |
| Accounts payable and accrued liabilities | -630 | 5,209 | 1,614 | 85 | 1,589 |
| Other Working Capital | -31,596 | -18,401 | 20,121 | -19,022 | 9,113 |
| Other Operating Activity | 38,684 | 29,037 | 32,615 | 22,256 | 20,339 |
| Operating Cash Flow | $-249,465 | $-172,584 | $-81,365 | $-159,807 | $-84,365 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,002 | -9,273 | -8,401 | -12,244 | -5,661 |
| Purchase Of Investment | -455,688 | -707,953 | -246,334 | -239,366 | -348,497 |
| Sale Of Investment | 617,543 | 459,513 | 323,036 | 278,808 | 245,907 |
| Investing Cash Flow | $147,853 | $-257,713 | $68,301 | $27,198 | $-108,251 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,880 | 296,950 | 3,217 | 22,433 | 153,883 |
| Common Stock Repurchased | 0 | -15 | 0 | N/A | -1 |
| Other Financing Activity | 234,762 | 188,732 | 0 | 94,759 | 0 |
| Financing Cash Flow | $238,642 | $485,667 | $3,217 | $117,192 | $153,882 |
| Beginning Cash Position | 110,898 | 55,528 | 65,375 | 80,792 | 119,526 |
| End Cash Position | 247,928 | 110,898 | 55,528 | 65,375 | 80,792 |
| Net Cash Flow | $137,030 | $55,370 | $-9,847 | $-15,417 | $-38,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -249,465 | -172,584 | -81,365 | -159,807 | -84,365 |
| Capital Expenditure | -14,002 | -9,273 | -8,401 | -12,244 | -5,661 |
| Free Cash Flow | -263,467 | -181,857 | -89,766 | -172,051 | -90,026 |